Patents by Inventor Theodore Witek

Theodore Witek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070099949
    Abstract: A method for improving the ability of a patient suffering from a lung disease to participate in and benefit from a pulmonary rehabilitation program, the method comprising administering to the patient a therapeutically effective amount of a tiotropium salt.
    Type: Application
    Filed: August 31, 2006
    Publication date: May 3, 2007
    Applicants: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Bernd Disse, Steven Kesten, Theodore Witek
  • Publication number: 20060205758
    Abstract: A method for reducing the mortality rate in a patient comprising administering to the patient a therapeutically effective amount of a tiotropium salt.
    Type: Application
    Filed: May 15, 2006
    Publication date: September 14, 2006
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Bernd Disse, Steven Kesten, Theodore Witek
  • Publication number: 20040102469
    Abstract: A method for reducing the mortality rate in a patient comprising administering to the patient a therapeutically effective amount of a tiotropium salt.
    Type: Application
    Filed: August 14, 2003
    Publication date: May 27, 2004
    Applicants: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingeilheim Pharmaceuticals, Inc.
    Inventors: Bernd Disse, Steven Kesten, Theodore Witek
  • Publication number: 20040102470
    Abstract: A method for improving the ability of a patient suffering from a lung disease to participate in and benefit from a pulmonary rehabilitation program, the method comprising administering to the patient a therapeutically effective amount of a tiotropium salt.
    Type: Application
    Filed: August 14, 2003
    Publication date: May 27, 2004
    Applicants: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Bernd Disse, Steven Kesten, Theodore Witek